- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Geistlich Pharma AG
Total 556 results
-
Assistance Publique - Hôpitaux de ParisRoche Pharma AGCompletedComparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab (MAINRITSAN3)ANCA-associated VasculitidesFrance
-
University of California, San FranciscoRoche Pharma AGCompletedHIV Infections | Cytomegalovirus InfectionsUnited States
-
Hospital Italiano de Buenos AiresRoche Pharma AGUnknownCOVID-19 | SARS-CoV 2 | Health Personnel
-
Fundación Academia Española de DermatologíaRoche Pharma AGCompletedMelanoma | Carcinoma, Squamous Cell | Carcinoma, Basal Cell | Skin Neoplasms | Histiocytoma, Malignant Fibrous | Dermatofibrosarcoma | Neoplasms, Adnexal and Skin AppendageSpain
-
Polish Myeloma ConsortiumRoche Pharma AG; Bioscience, S.A.UnknownWaldenstrom MacroglobulinemiaPoland
-
Hospital General Universitario Gregorio MarañonRoche Pharma AGUnknown
-
Groupe Francophone des MyelodysplasiesRoche Pharma AG; CelgeneCompletedMyelodysplastic SyndromesFrance, Monaco
-
Tehran University of Medical SciencesTillotts Pharma AGWithdrawnQuality of Life | Diarrhea- Predominant Irritable Bowel SyndromeIran, Islamic Republic of
-
Dutch Colorectal Cancer GroupSanofi; Roche Pharma AGTerminatedColorectal Cancer | Liver MetastasesNetherlands
-
TME Pharma AGProfil Institut für Stoffwechselforschung GmbHCompletedType 2 Diabetes MellitusGermany
-
Ontario Clinical Oncology Group (OCOG)Roche Pharma AGCompletedNon-small Cell Lung CancerCanada
-
Mashhad University of Medical SciencesRoche Pharma AGCompletedDMARD Resistant Rheumatoid ArthritisIran, Islamic Republic of
-
National Cancer Center, KoreaPfizer; Roche Pharma AGUnknownNSCLC | Lung CancerKorea, Republic of
-
Royal Free Hampstead NHS TrustRoche Pharma AGCompleted
-
Pennine Acute Hospitals NHS TrustRoche Pharma AGUnknownHepatitis CUnited Kingdom
-
Nykode Therapeutics ASARoche Pharma AG; GOG FoundationRecruitingCervical Cancer | HPV-Related Malignancy | HPV-Related Cervical CarcinomaUnited States
-
National Taiwan University HospitalRoche Pharma AG; IpsenRecruitingEsophageal Cancer | Metastatic Cancer | Squamous Cell CarcinomaTaiwan
-
The Lymphoma Academic Research OrganisationRoche Pharma AGCompleted
-
The Netherlands Cancer InstituteRoche Pharma AG; AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungNetherlands
-
Assistance Publique - Hôpitaux de ParisRoche Pharma AGCompletedPulmonary FibrosisFrance
-
Federation Francophone de Cancerologie DigestiveRoche Pharma AGCompleted
-
Nantes University HospitalRoche Pharma AG; Janssen, LPActive, not recruitingMantle Cell LymphomaFrance, United Kingdom
-
Martin-Luther-Universität Halle-WittenbergRoche Pharma AGCompletedMetastatic Colorectal CancerGermany
-
Maastricht University Medical CenterWill-Pharma; Medigene AGCompletedCarcinoma, Basal CellNetherlands
-
Fundación Leucemia y Linfoma, SpainRoche Pharma AGCompletedNon-Hodgkin's LymphomaSpain
-
University of PittsburghRoche Pharma AG; Aventis PharmaceuticalsTerminated
-
University of California, San FranciscoRoche Pharma AGCompleted
-
Arbeitsgemeinschaft medikamentoese TumortherapieRoche Pharma AG; Celgene CorporationCompletedLeukemia, Lymphocytic, Chronic, B-CellAustria
-
University of CologneSanofi; Novartis; Roche Pharma AGCompleted
-
Charite University, Berlin, GermanySanofi; Roche Pharma AGUnknown
-
Peking University Cancer Hospital & InstituteRoche Pharma AGUnknown
-
German Breast GroupRoche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor PharmaCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
Göteborg UniversityKing's College London; Charite University, Berlin, Germany; Geistlich Pharma AG; Queen Mary University of London and other collaboratorsNot yet recruitingPeriodontitis | Furcation DefectsSweden
-
Association Aquitaine de Recherche Clinique en...Roche Pharma AG; Chugai Pharma FranceCompletedArthritis, Rheumatoid | Tocilizumab | T-Lymphocytes, Helper-InducerFrance
-
University Hospital FreiburgRoche Pharma AG; Genzyme, a Sanofi Company; Astellas Pharma GmbHCompletedDisorder Related to Renal TransplantationGermany
-
Gustave Roussy, Cancer Campus, Grand ParisRoche Pharma AGRecruiting
-
AIO-Studien-gGmbHRoche Pharma AG; Immodulon Therapeutics LtdRecruiting
-
University Hospital, Basel, SwitzerlandNovartis Pharma AG, Basel, SwitzerlandCompletedMultiple Sclerosis (MS)Switzerland
-
Instituto Nacional de Cancerologia de MexicoRoche Pharma AGCompletedALK Gene Rearrangement Positive | Non-Squamous Non-Small Cell Neoplasm of LungMexico
-
Borstkanker Onderzoek GroepRoche Pharma AG; BOOG Study CenterActive, not recruiting
-
Intergroupe Francophone de Cancerologie ThoraciqueRoche Pharma AG; GFPCCompletedSmall Cell Lung CancerFrance
-
Friedemann PaulRoche Pharma AGActive, not recruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveGermany
-
King's College LondonRoche Pharma AG; Medical Research CouncilCompletedKidney Transplantation | Graft Rejection | ImmunosuppressionUnited Kingdom
-
Centre Jean PerrinRoche Pharma AG; NanoString Technologies, Inc.Terminated
-
Molecular NeuroImagingRoche Pharma AG; Institute for Neurodegenerative DisordersCompletedAlzheimer's Disease (AD)United States
-
Göteborg UniversityThe Swedish Research Council; Roche Pharma AGCompleted
-
University College, LondonRoche Pharma AG; Cancer Research UKTerminatedLung Cancer | Metastatic CancerUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustRoche Pharma AGCompletedSystemic Lupus Erythematosus | ANCA Associated VasculitisUnited Kingdom
-
Institut CurieRoche Pharma AG; National Research Agency, FranceNot yet recruitingTriple Negative Breast CancerFrance
-
University College, LondonRoche Pharma AG; Cancer Research UKCompletedLymphomaNew Zealand, United Kingdom, Australia